Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (2)
  • 2024 (1)
  • 2023 (3)
  • 2022 (2)
  • 2021 (2)

Subject

  • Drug Trafficking (251)
  • Arrests/Convictions - Major (82)
  • Guilty Plea (65)
  • OCDETF/Task Force (55)
  • Guns/Weapons (31)
  • Synthetic drugs (27)
  • Prescription Drugs (18)
  • Money Laundering (17)
  • Pharmaceuticals/Pharmacists/Physicians (16)
  • Fake Pills (15)
  • Overdose (12)
  • Take Back Day (12)
  • Seizures (Drugs/Property) (10)
  • Outreach/Drug Prevention (7)
  • Fentanyl Awareness (6)
  • Major Law Enforcement Operation (6)
  • HIDTA (5)
  • Extraditions (4)
  • One Pill Can Kill (4)
  • Asset Forfeiture (3)
  • Task Forces/Task Force Officers (3)
  • Dark Web- Internet Trafficking (2)
  • Intelligence Division - Intelligence Products (1)
  • International/Foreign Operations (1)
  • Public and Media Affairs - also see Congressional Affairs (1)
  • Diversion Division (9)
  • Intergovernmental Affairs (1)

Drug Name

  • Amphetamines (2)
  • Opioids (2)
  • Fentanyl (1)
  • Oxycodone (1)

Field Division

  • Washington, DC (36)
  • New England (33)
  • New York (23)
  • Seattle (22)
  • Chicago (18)
  • Houston (15)
  • New Jersey (15)
  • Atlanta (13)
  • Sede (12)
  • New Orleans (8)
  • San Francisco (7)
  • St. Louis (7)
  • El Paso (6)
  • Dallas (5)
  • Rocky Mountain (5)
  • San Diego (4)
  • Los Angeles (3)
  • Omaha (3)
  • Phoenix (3)
  • Louisville (2)
  • Detroit (1)
  • Miami (10)
Clear All Results
PRESS RELEASE

Pensacola Women Plead Guilty to Illegal Drug Diversion

Noviembre 17, 2025
PENSACOLA, FLA – Alexandra M. Christensen, 31, Lindsay N. McCray (also known as Lindsay Rogers), 42, Heather T. Bradley (also known as Heather Thomas), 37, and Jennifer E. Purves, 39, all of Pensacola, Fla., pleaded guilty in federal court to charges in connection with the unlawful diversion of controlled substances...
Noviembre 17, 2025
PRESS RELEASE

Four Pensacola Women Charged with Illegal Drug Diversion

Junio 30, 2025
PENSACOLA, FLA. – Today, United States Attorney John P. Heekin announced criminal charges against four defendants with an alleged scheme to unlawfully divert oxycodone, hydrocodone, and amphetamine. The charges filed in federal court are part of the Department of Justice’s 2025 National Health Care Fraud Takedown. All the cases are...
Junio 30, 2025
PRESS RELEASE

Nearly 630,000 Pounds of Unneeded Medications Collected on DEA’s National Prescription Drug Take Back Day

Noviembre 15, 2024
MIAMI — Drug Enforcement Administration (DEA) and more than 4,400 law enforcement partners recently collected nearly 630,000 pounds of unused medications at 4,600 locations nationwide. This effort to empty medicine cabinets helps prevent drug misuse before it starts. Since its inception, DEA’s National Prescription Drug Take Back Day has removed...
Noviembre 15, 2024
PRESS RELEASE

Christian & Missionary Alliance Foundation, Inc. Agrees to Pay $250,000 to Resolve Alleged Violations of the Controlled Substances Act

Agosto 03, 2023
FORT MYERS, Fla. - United States Attorney Roger Handberg announced that the Christian & Missionary Alliance Foundation, Inc. has agreed to pay the United States $250,000 to resolve allegations that the Christian & Missionary Alliance Foundation, Inc. violated the Controlled Substances Act (CSA) by failing to maintain records required by...
Agosto 03, 2023
PRESS RELEASE

Panama City Physician Pays $225,000 to Settle Allegations that He Overprescribed Controlled Substances

Marzo 21, 2023
PENSACOLA, Fla. – Dr. George Barrio, a pain management physician who formerly practiced medicine at the NeuroMedical Institute in Panama City, agreed to pay $225,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances to patients. The settlement was announced by Jason R. Coody, United States Attorney...
Marzo 21, 2023
PRESS RELEASE

Physician Agrees to $190,731 Settlement Relating to Controlled Substances Act Claims

Febrero 24, 2023
PENSACOLA, Fla. – Timothy Ramsden, of Panama City, Florida, practicing at The Anti-Aging Clinic of Northwest Florida, settled potential violations of the Controlled Substances Act by agreeing to pay a fine of $190,731 and surrendering his Drug Enforcement Administration (DEA) registration for Schedule II and IIN controlled substances for a...
Febrero 24, 2023
PRESS RELEASE

Justice Department Obtains Temporary Restraining Order to Prevent Tampa-Area Physician from Writing Opioid Prescriptions

Julio 29, 2022
WASHINGTON – A federal court issued a temporary restraining order prohibiting a Tampa-area physician from prescribing opioids and other controlled substances, the Department of Justice announced today. In a complaint filed on July 18, and unsealed yesterday, the United States alleges that Dr. Neelam Taneja Uppal unlawfully wrote opioid prescriptions...
Julio 29, 2022
PRESS RELEASE

Bonifay Doctor Settles Controlled Substances Act Violations For $130,000

Julio 06, 2022
PENSACOLA, Fla. —Ahmad T. Ismail, 70, of Bonifay, Florida, settled potential violations of the Controlled Substances Act by agreeing to pay a fine of $130,000 and surrendering his Drug Enforcement Administration (DEA) registration. The settlement was announced by Jason R. Coody, United States Attorney for the Northern District of Florida...
Julio 06, 2022
PRESS RELEASE

Naples Doctor Who Operated a Pill Mill Sentenced to Three Years in Federal Prison

Diciembre 06, 2021
FORT MYERS, Fla. – U.S. District Judge Sheri Polster Chappell today sentenced Gerald Michael Abraham, 76, of Naples, Florida. to three years in federal prison for dispensing controlled substances (oxycodone and amphetamine) for no legitimate medical purpose. The court also ordered Abraham to forfeit the following items to the United...
Diciembre 06, 2021
PRESS RELEASE

New Reward Offered for the Capture of Jian Zhang

Agosto 30, 2021
MIAMI, Fla. – The U.S. Drug Enforcement Administration (DEA) and the U.S. Department of State today announced a new reward for information that will lead to the location, arrest, and/or conviction of People’s Republic of China (PRC) national Jian Zhang, a key leader of a transnational criminal organization known as...
Agosto 30, 2021
Showing 1 - 10 of 10 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster